[go: up one dir, main page]

DE69400312D1 - Zusammensetzung bestehend aus einem rekombinanten lebenden untereinheitsimpfstoff und verfahren zur herstellung - Google Patents

Zusammensetzung bestehend aus einem rekombinanten lebenden untereinheitsimpfstoff und verfahren zur herstellung

Info

Publication number
DE69400312D1
DE69400312D1 DE69400312T DE69400312T DE69400312D1 DE 69400312 D1 DE69400312 D1 DE 69400312D1 DE 69400312 T DE69400312 T DE 69400312T DE 69400312 T DE69400312 T DE 69400312T DE 69400312 D1 DE69400312 D1 DE 69400312D1
Authority
DE
Germany
Prior art keywords
production
composition consisting
unit vaccine
recombinant living
living sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69400312T
Other languages
English (en)
Other versions
DE69400312T2 (de
Inventor
Vincent Ganne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Application granted granted Critical
Publication of DE69400312D1 publication Critical patent/DE69400312D1/de
Publication of DE69400312T2 publication Critical patent/DE69400312T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69400312T 1993-01-29 1994-01-28 Zusammensetzung bestehend aus einem rekombinanten lebenden untereinheitsimpfstoff und verfahren zur herstellung Expired - Fee Related DE69400312T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9300942A FR2700957B1 (fr) 1993-01-29 1993-01-29 Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
PCT/FR1994/000106 WO1994016681A1 (fr) 1993-01-29 1994-01-28 Composition de vaccin sous unitaire recombinant vivant et procede de preparation

Publications (2)

Publication Number Publication Date
DE69400312D1 true DE69400312D1 (de) 1996-08-22
DE69400312T2 DE69400312T2 (de) 1996-11-21

Family

ID=9443503

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69400312T Expired - Fee Related DE69400312T2 (de) 1993-01-29 1994-01-28 Zusammensetzung bestehend aus einem rekombinanten lebenden untereinheitsimpfstoff und verfahren zur herstellung

Country Status (8)

Country Link
EP (1) EP0681470B1 (de)
JP (2) JPH08505866A (de)
CA (1) CA2154902A1 (de)
DE (1) DE69400312T2 (de)
DK (1) DK0681470T3 (de)
ES (1) ES2089923T3 (de)
FR (1) FR2700957B1 (de)
WO (1) WO1994016681A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
FR2717694B1 (fr) * 1994-03-22 1996-05-03 Seppic Sa Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2800280B1 (fr) 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
FR2809961B1 (fr) * 2000-06-09 2004-12-03 Seppic Sa Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins
JP2002030098A (ja) * 2000-07-17 2002-01-29 Institute Of Immunology Co Ltd バキュロウィルスの発芽ウイルスからウイルスエンベロープを回収する方法
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
WO2002062381A1 (fr) * 2001-02-05 2002-08-15 Hisamitsu Pharmaceutical Co., Inc. Vaccin a vecteur de baculovirus
JP4685350B2 (ja) 2001-07-26 2011-05-18 オタゴ イノベイション リミティド 抗原性組成物
AU2008202282B8 (en) * 2001-07-26 2009-08-13 Agresearch Limited Immunogenic Compositions
WO2003020322A1 (de) * 2001-09-04 2003-03-13 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Vektor zur induktion einer immunantwort
FR2922767B1 (fr) 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
FR2649013B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
AU9179891A (en) * 1990-12-19 1992-07-22 Epitope, Inc. Hiv reverse transcriptase vaccine

Also Published As

Publication number Publication date
FR2700957B1 (fr) 1995-03-03
CA2154902A1 (fr) 1994-08-04
ES2089923T3 (es) 1996-10-01
JPH08505866A (ja) 1996-06-25
FR2700957A1 (fr) 1994-08-05
DE69400312T2 (de) 1996-11-21
EP0681470B1 (de) 1996-07-17
EP0681470A1 (de) 1995-11-15
JP2004137283A (ja) 2004-05-13
DK0681470T3 (da) 1996-08-12
WO1994016681A1 (fr) 1994-08-04

Similar Documents

Publication Publication Date Title
DE69400312D1 (de) Zusammensetzung bestehend aus einem rekombinanten lebenden untereinheitsimpfstoff und verfahren zur herstellung
DE69216500D1 (de) Härtbare Harzzusammensetzungen und Verfahren zur Herstellung
DE69635445D1 (de) Alkalialuminiumhydroxycarbonatzusammensetzung und verfahren zur herstellung
DE69511571D1 (de) Verfahren zur herstellung von essbaren hüllen und daraus hergestellten zusammensetzungen
DE69316810D1 (de) SiGe-SOI-MOSFET und Verfahren zur Herstellung
DE69623926D1 (de) Kugelgelenk und verfahren zur herstellung
DE59401343D1 (de) Medizinisches pflastermaterial sowie verfahren zu seiner herstellung
DE69418851D1 (de) Verfahren zur Herstellung von Befestigungsvorrichtungen
DE69512304D1 (de) Verbund-Polymer-Implantat und Verfahren zur Herstellung desselben
DE69529966D1 (de) Tintenzusammensetzung und Verfahren zur Herstellung derselben
DE69231641D1 (de) Geformter Mehrschicht-Gegenstand und Verfahren zur dessen Herstellung
DE69116934D1 (de) Schiffsrumpf und Verfahren zur Herstellung
DE59507799D1 (de) Bindemittelzusammensetzung zur herstellung von faservliesen und verfahren zur herstellung von faservlies-formteilen
DE69118511D1 (de) EPROM und Verfahren zur Herstellung
DE69231144D1 (de) Beschichteter Körper und Verfahren zur Herstellung derselben
DE69324511D1 (de) Mehrschichtig geformter Gegenstand und Verfahren zur dessen Herstellung
DE69519739D1 (de) Epdm zusammensetzungen und verfahren zur herstellung davon
DE59404999D1 (de) Verfahren zur Herstellung anorganischer diffraktiver Elemente und Verwendung derselben
DE69832282D1 (de) Polysilazan-amine und verfahren zur herstellung
DE69328985D1 (de) Gate-gesteuerte Diode und Verfahren zur Herstellung derselben
DE59405194D1 (de) Copolymerisate ungesättigter carbonsäuren, verfahren zur herstellung und ihre verwendung
DE69518821D1 (de) Coulomb-Blockade-Element und Verfahren zur Herstellung
DE69232547D1 (de) Keramische Partikel und Verfahren zur ihren Herstellung
DE69227722D1 (de) Drehender Dichtungselement und Verfahren zur Herstellung
DE69327041D1 (de) Poroeses polytetrafluorethylen-material und verfahren zur herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee